Boehringer’s sales decline in first 2010 half, expects increase in 2011

Boehringer Ingelheim GmbH, reported a 2.8% decline in sales in the first half of 2010, mainly due to generic competition in the US. But it said new product sales would help it achieve a high, single-digit increase in 2011.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany